BioVex raised €20M in a Series D+ round in Nov 2009. The company is based in Oxton, UK. Investors in the round: Morningside Group, Sectoral Asset Management, Ventech and 1 other. Data as of 6 Aug 2026.
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
